SCHEMBL2821

SCHEMBL2821

CCOC(=O)CC(C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7405660 1.00
SCHEMBL4846715 1.00
Hydrochloric Acid SCHEMBL852518 0.98 MGAM (0.48)
Hydrochloric Acid SCHEMBL14920670 0.98 MGAM (0.48)
Hydrochloric Acid SCHEMBL14920723 0.98 MGAM (0.48)
SCHEMBL8198022 0.83
SCHEMBL2582072 0.83 GAA (0.52)
SCHEMBL333919 0.82 GAA (0.46)
SCHEMBL6437102 0.82 NAAA (0.38)
Hydrochloric Acid SCHEMBL27969637 0.81 SOAT1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 559 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250332226-A1 COMPOSITIONS AND METHODS FOR TREATING SOLID CANCER EXOXEMIS INC (US) 2025-10-30 US claimed
CN-120059029-A Vinyl acetate copolymer and preparation method and application thereof 云南正邦科技有限公司 2025-05-30 CN claimed
CN-119591534-A Bromo-pyrrole nitrile-beta-aminobutyric acid derivative and preparation method and application thereof 长江大学 2025-03-11 CN claimed
EP-4507793-A1 COMPOSITIONS AND METHODS FOR TREATING SOLID CANCER Exoxemis, Inc. (US) 2025-02-19 EP claimed
WO-2023214011-A1 ENZYMATIC METHOD FOR PREPARING (R)-3-AMINO-4-ARYL-BUTANOIC ACID DERIVATIVES ENZYMICALS AG (DE) 2023-11-09 WO claimed
EP-4273254-A1 ENZYMATIC METHOD FOR PREPARING (R)-3-AMINO-4-ARYL-BUTANOIC ACID DERIVATIVES Enzymicals AG (DE) 2023-11-08 EP claimed
CN-116948060-A Method for hydrogenation of nitrile rubber by single ruthenium catalyst 西安凯立新材料股份有限公司 2023-10-27 CN claimed
WO-2023200842-A1 COMPOSITIONS AND METHODS FOR TREATING SOLID CANCER EXOXEMIS, INC. (US) 2023-10-19 WO claimed
CN-115850240-B Synthesis method of medicine ao Lu Taxi Ni for treating acute myelogenous leukemia 北京康立生医药技术开发有限公司 2023-09-19 CN claimed
CN-116554081-A Synthesis method of 3-phenyl-1-propyl-1H-isoindolecarboxylic acid 宿迁德威化工股份有限公司 2023-08-08 CN claimed
US-6989402-B1 Thyroid receptor ligands and method II KARO BIO AB (SE) 2006-01-24 US claimed
US-20050282872-A1 Novel thyroid receptor ligands and method II HANGELAND JON 2005-12-22 US claimed
EP-1603549-A2 IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS Yu, Ruey J., Dr. (US) 2005-12-14 EP claimed
CN-1186332-C Novel thyroid receptor ligands and method II KAROBIO AB (SE) 2005-01-26 CN claimed
CN-1558898-A Antiviral agent ��Ұ����ҩ��ʽ���� 2004-12-29 CN claimed
US-20040220264-A1 Bioavailability and improved delivery of acidic pharmaceutical drugs YU RUEY J 2004-11-04 US claimed
WO-2004082628-A2 IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ACIDIC PHARMACEUTICAL DRUGS YU RUEY J (US) 2004-09-30 WO claimed
EP-1422218-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2004-05-26 EP claimed
CN-1337953-A Novel thyroid receptor ligands and method II KAROBIO AB (SE) 2002-02-27 CN claimed
CN-1123544-A Optically active 3-(1-(alkylamino)) alkyl pyrrolidines UPJOHN CO (US) 1996-05-29 CN claimed